Travere Therapeutics (TVTX) Inventory Average (2014 - 2026)
Travere Therapeutics (TVTX) posted Inventory Average of $6.1 million for Q1 2026, up 7.07% on a QoQ basis from $5.7 million in Q4 2025, and up 20.72% year-over-year from $5.1 million in Q1 2025.
Travere Therapeutics (TVTX) Inventory Average (2014 - 2026) Analysis & Trends
Travere Therapeutics' Inventory Average history runs 13 years deep, the most recent figure standing at $6.1 million for Q1 2026.
- Quarterly Inventory Average rose 20.72% year-over-year to $6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.1 million (up 20.72% YoY) and the FY2025 annual result came in at $6.0 million, down 22.65% from the prior year.
- Inventory Average was $6.1 million for Q1 2026 at Travere Therapeutics, up from $5.7 million in the prior quarter.
- Across five years, Inventory Average topped out at $19.8 million in Q3 2023 and bottomed at $4.0 million in Q2 2025.
- A 5-year average of $7.7 million and a median of $6.2 million in 2024 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2023 — Inventory Average soared 164.84% — and 2024, when it sank 68.81%.
- Travere Therapeutics' Inventory Average stood at $5.9 million in 2022, then soared by 155.36% to $15.1 million in 2023, then sank by 58.4% to $6.3 million in 2024, then declined by 9.02% to $5.7 million in 2025, then rose by 7.07% to $6.1 million in 2026.
- Business Quant data shows TVTX's Inventory Average at $6.1 million in Q1 2026, $5.7 million in Q4 2025, and $4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn | 6.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.12 Mn |
| Dec 31, 2025 | 5.71 Mn |
| Sep 30, 2025 | 4.82 Mn |
| Jun 30, 2025 | 4.01 Mn |
| Mar 31, 2025 | 5.07 Mn |
| Dec 31, 2024 | 6.28 Mn |
| Sep 30, 2024 | 6.17 Mn |
| Jun 30, 2024 | 5.25 Mn |
| Mar 31, 2024 | 6.97 Mn |
| Dec 31, 2023 | 15.09 Mn |
| Sep 30, 2023 | 19.77 Mn |
| Jun 30, 2023 | 12.74 Mn |
| Mar 31, 2023 | 5.62 Mn |
| Dec 31, 2022 | 5.91 Mn |
| Sep 30, 2022 | 7.46 Mn |
| Jun 30, 2022 | 7.08 Mn |
| Mar 31, 2022 | 6.92 Mn |
| Dec 31, 2021 | 6.96 Mn |
| Sep 30, 2021 | 7.01 Mn |
| Jun 30, 2021 | 7.30 Mn |